|
|
|
A strategy for designing more effective
cholesterol-lowering drugs may come
from the first studies of the structural
mechanism by which the widely
prescribed statin drugs, such as Lipitor
and Zocor, lower cholesterol.
Although the statin drugs -- which are regarded
as blockbuster drugs for the
pharmaceutical industry -- are effective at
reducing cholesterol, the new
structural studies suggest there is room for
improvement.
Research published in the May 11, 2001,
issue of the journal Science.For the full story go to
http://www.hhmi.org/news/deisenhofer.html
Message posted by: hhmi
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|